Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results
Daver, Naval G, Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M, Larson, Richard A, Asch, Adam S, Mannis, Gabriel, Chai-Ho, Wanxing, Tanaka, Tiffany N, Bradley, Terrence J, Jeyakumar, Deepa, Wang, Eunice S, Sweet, Kendra, Kantarjian, Hagop M, Garcia-Manero, Guillermo, Komrokji, Rami, Xing, Guan, Ramsingh, Giridharan, Renard, Camille, Zeidner, Joshua F, Sallman, David A
Published in Journal of clinical oncology (01.11.2023)
Published in Journal of clinical oncology (01.11.2023)
Get full text
Journal Article
A phase II open label, single arm study to evaluate the efficacy of pembrolizumab for leukoplakia
Porter, Ashleigh, Zeh, Audrey J., Ly, Thu, Serna, Alyssa, Villanueva, Arturo, Chai-Ho, Wanxing, Messadi, Diana, Maie, St. John, Wang, Marilene, Abemayor, Eliot, Cohen, Ezra E.W., Wong, Deborah J.L.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma (CERPASS)
Haydon, Andrew Mark, Khushalani, Nikhil I., Robert, Caroline, Brungs, Daniel, Collichio, Frances A., Colevas, A. Dimitrios, Lim, Annette May Ling, Kudchadkar, Ragini Reiney, Chai-Ho, Wanxing, Daniels, Gregory A., Lutzky, Jose, Lee, Jenny HJ, Silk, Ann W., Lebbe, Celeste, Grob, Jean-Jacques, Smith, Margaret, Fury, Matthew G., Alamgeer, Muhammad, Hill, Andrew Graham, Migden, Michael Robert
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
An open-label, multicenter, phase 1b/2 study of RP1, a first-in-class, enhanced potency oncolytic virus in solid organ transplant recipients with advanced cutaneous malignancies (ARTACUS)
Migden, Michael Robert, Luke, Jason J., Chai-Ho, Wanxing, Kheterpal, Meenal, Wise-Draper, Trisha Michel, Poklepovic, Andrew Stewart, Bolotin, Diana, Verschraegen, Claire F., Collichio, Frances A., Tang, Jennifer, Daniels, Gregory A., Tsai, Katy K., Navia, Susan Benedict, Zhang, Haifeng, Ahlers, Christoph Matthias
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results
Daver, Naval Guastad, Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M., Larson, Richard A., Asch, Adam Steven, Mannis, Gabriel N., Chai-Ho, Wanxing, Tanaka, Tiffany N., Bradley, Terrence J., Jeyakumar, Deepa, Wang, Eunice S., Xing, Guan, Chao, Mark, Ramsingh, Giridharan, Renard, Camille, Lal, Indu, Zeidner, Joshua F., Sallman, David Andrew
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article